The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Glomerular Filtration Rate

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Glomerular Filtration Rate


Psychiatry related information on Glomerular Filtration Rate


High impact information on Glomerular Filtration Rate


Chemical compound and disease context of Glomerular Filtration Rate


Biological context of Glomerular Filtration Rate


Anatomical context of Glomerular Filtration Rate


Associations of Glomerular Filtration Rate with chemical compounds


Gene context of Glomerular Filtration Rate


Analytical, diagnostic and therapeutic context of Glomerular Filtration Rate


  1. Partial normalization by dietary cod-liver oil of increased microvascular albumin leakage in patients with insulin-dependent diabetes and albuminuria. Jensen, T., Stender, S., Goldstein, K., Hølmer, G., Deckert, T. N. Engl. J. Med. (1989) [Pubmed]
  2. Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes. Serri, O., Beauregard, H., Brazeau, P., Abribat, T., Lambert, J., Harris, A., Vachon, L. JAMA (1991) [Pubmed]
  3. Structural-functional relationships in diabetic nephropathy. Mauer, S.M., Steffes, M.W., Ellis, E.N., Sutherland, D.E., Brown, D.M., Goetz, F.C. J. Clin. Invest. (1984) [Pubmed]
  4. Role of atrial natriuretic peptide in adaptation of sodium excretion with reduced renal mass. Smith, S., Anderson, S., Ballermann, B.J., Brenner, B.M. J. Clin. Invest. (1986) [Pubmed]
  5. Heparin-binding EGF-like growth factor contributes to reduced glomerular filtration rate during glomerulonephritis in rats. Feng, L., Garcia, G.E., Yang, Y., Xia, Y., Gabbai, F.B., Peterson, O.W., Abraham, J.A., Blantz, R.C., Wilson, C.B. J. Clin. Invest. (2000) [Pubmed]
  6. Antihypertensive therapy in a model combining spontaneous hypertension with diabetes. Cooper, M.E., Rumble, J.R., Allen, T.J., O'Brien, R.C., Jerums, G., Doyle, A.E. Kidney Int. (1992) [Pubmed]
  7. Carboplatin dosing: gender bias and inaccurate estimates of glomerular filtration rate. Dooley, M.J., Poole, S.G., Rischin, D., Webster, L.K. Eur. J. Cancer (2002) [Pubmed]
  8. Effect of alcohol consumption on estimated glomerular filtration rate and creatinine clearance rate. Chung, F.M., Yang, Y.H., Shieh, T.Y., Shin, S.J., Tsai, J.C., Lee, Y.J. Nephrol. Dial. Transplant. (2005) [Pubmed]
  9. Renal function in chronic lithium-treated patients. Conte, G., Vazzola, A., Sacchetti, E. Acta psychiatrica Scandinavica. (1989) [Pubmed]
  10. Association of socio-psychological factors with the effects of low protein diet for the prevention of the progression of chronic renal failure. Kanazawa, Y., Nakao, T., Ohya, Y., Shimomitsu, T. Intern. Med. (2006) [Pubmed]
  11. Functional adaptation to reduction in renal mass. Hayslett, J.P. Physiol. Rev. (1979) [Pubmed]
  12. Increased glomerular filtration rate in kidney-transplant recipients who take sildenafil. Rostaing, L., Tran-Van, T., Ader, J.L. N. Engl. J. Med. (2000) [Pubmed]
  13. Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. Allgren, R.L., Marbury, T.C., Rahman, S.N., Weisberg, L.S., Fenves, A.Z., Lafayette, R.A., Sweet, R.M., Genter, F.C., Kurnik, B.R., Conger, J.D., Sayegh, M.H. N. Engl. J. Med. (1997) [Pubmed]
  14. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. Nelson, R.G., Bennett, P.H., Beck, G.J., Tan, M., Knowler, W.C., Mitch, W.E., Hirschman, G.H., Myers, B.D. N. Engl. J. Med. (1996) [Pubmed]
  15. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. Falk, R.J., Scheinman, J., Phillips, G., Orringer, E., Johnson, A., Jennette, J.C. N. Engl. J. Med. (1992) [Pubmed]
  16. Glomerular dynamics and morphologic changes in the generalized Shwartzman reaction in postpartum rats. Conger, J.D., Falk, S.A., Guggenheim, S.J. J. Clin. Invest. (1981) [Pubmed]
  17. Volume-independent reductions in glomerular filtration rate in acute chloride-depletion alkalosis in the rat. Evidence for mediation by tubuloglomerular feedback. Galla, J.H., Bonduris, D.N., Sanders, P.W., Luke, R.G. J. Clin. Invest. (1984) [Pubmed]
  18. Sodium excretion and sympathetic activity in relation to severity of hypertensive disease. Berglund, G., Wikstrand, J., Wallentin, I., Wilhelmsen, L. Lancet (1976) [Pubmed]
  19. Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites. Bosch-Marcè, M., Clària, J., Titos, E., Masferrer, J.L., Altuna, R., Poo, J.L., Jiménez, W., Arroyo, V., Rivera, F., Rodés, J. Gastroenterology (1999) [Pubmed]
  20. Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats. Bardoux, P., Martin, H., Ahloulay, M., Schmitt, F., Bouby, N., Trinh-Trang-Tan, M.M., Bankir, L. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  21. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin. Ciabattoni, G., Cinotti, G.A., Pierucci, A., Simonetti, B.M., Manzi, M., Pugliese, F., Barsotti, P., Pecci, G., Taggi, F., Patrono, C. N. Engl. J. Med. (1984) [Pubmed]
  22. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. Tuttle, K.R., Bruton, J.L., Perusek, M.C., Lancaster, J.L., Kopp, D.T., DeFronzo, R.A. N. Engl. J. Med. (1991) [Pubmed]
  23. Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial. Ellis, C.N., Fradin, M.S., Messana, J.M., Brown, M.D., Siegel, M.T., Hartley, A.H., Rocher, L.L., Wheeler, S., Hamilton, T.A., Parish, T.G. N. Engl. J. Med. (1991) [Pubmed]
  24. Increased glomerular filtration rate in patients with major burns and its effect on the pharmacokinetics of tobramycin. Loirat, P., Rohan, J., Baillet, A., Beaufils, F., David, R., Chapman, A. N. Engl. J. Med. (1978) [Pubmed]
  25. Endothelium-derived relaxing factor inhibits transport and increases cGMP content in cultured mouse cortical collecting duct cells. Stoos, B.A., Carretero, O.A., Farhy, R.D., Scicli, G., Garvin, J.L. J. Clin. Invest. (1992) [Pubmed]
  26. Deep nephron function after release of acute unilateral ureteral obstruction in the young rat. Buerkert, J., Martin, D., Head, M., Prasad, J., Klahr, S. J. Clin. Invest. (1978) [Pubmed]
  27. A regulatory role for large vessels in organ circulation. Endothelial cells of the main renal artery modulate intrarenal hemodynamics in the rat. Kon, V., Harris, R.C., Ichikawa, I. J. Clin. Invest. (1990) [Pubmed]
  28. Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways. Badr, K.F., Murray, J.J., Breyer, M.D., Takahashi, K., Inagami, T., Harris, R.C. J. Clin. Invest. (1989) [Pubmed]
  29. In vivo evidence that cGMP is the second messenger for atrial natriuretic factor. Huang, C.L., Ives, H.E., Cogan, M.G. Proc. Natl. Acad. Sci. U.S.A. (1986) [Pubmed]
  30. Hepatorenal reflex regulating kidney function. Lang, F., Tschernko, E., Schulze, E., Ottl, I., Ritter, M., Völkl, H., Hallbrucker, C., Häussinger, D. Hepatology (1991) [Pubmed]
  31. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. Wiseman, M.J., Saunders, A.J., Keen, H., Viberti, G. N. Engl. J. Med. (1985) [Pubmed]
  32. Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate. Wharram, B.L., Goyal, M., Gillespie, P.J., Wiggins, J.E., Kershaw, D.B., Holzman, L.B., Dysko, R.C., Saunders, T.L., Samuelson, L.C., Wiggins, R.C. J. Clin. Invest. (2000) [Pubmed]
  33. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation. Hokken-Koelega, A.C., Stijnen, T., de Muinck Keizer-Schrama, S.M., Blum, W.F., Drop, S.L. J. Clin. Endocrinol. Metab. (1993) [Pubmed]
  34. Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. Nguyen, T.Q., Tarnow, L., Andersen, S., Hovind, P., Parving, H.H., Goldschmeding, R., van Nieuwenhoven, F.A. Diabetes Care (2006) [Pubmed]
  35. Insulin-like growth factor-binding protein-6 levels are elevated in serum of children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group. Powell, D.R., Liu, F., Baker, B.K., Hintz, R.L., Durham, S.K., Brewer, E.D., Frane, J.W., Tonshoff, B., Mehls, O., Wingen, A.M., Watkins, S.L., Hogg, R.J., Lee, P.D. J. Clin. Endocrinol. Metab. (1997) [Pubmed]
  36. Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy. Donadio, J.V., Anderson, C.F., Mitchell, J.C., Holley, K.E., Ilstrup, D.M., Fuster, V., Chesebro, J.H. N. Engl. J. Med. (1984) [Pubmed]
  37. Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy. Conger, J.D., Falk, S.A. J. Clin. Invest. (1977) [Pubmed]
  38. Intrarenal mechanisms of salt retention after bile duct ligation in rats. Yarger, W.E., Schrader, N.W., Boyd, M.A. J. Clin. Invest. (1976) [Pubmed]
  39. Renal vasoconstriction caused by short-term cholesterol feeding is corrected by thromboxane antagonist or probucol. Kaplan, R., Aynedjian, H.S., Schlondorff, D., Bank, N. J. Clin. Invest. (1990) [Pubmed]
  40. Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. Titó, L., Ginès, P., Arroyo, V., Planas, R., Panés, J., Rimola, A., Llach, J., Humbert, P., Badalamenti, S., Jiménez, W. Gastroenterology (1990) [Pubmed]
WikiGenes - Universities